form the intermediates 12 or 13. Intramolecular lactonization of the intermediate 12 leads to produce compound 6 and also,
intermediate 13 followed by a tautomeric proton shift leads to the formation of desired product 7.
3. Conclusion
In summary, we have described a novel domino three-component coupling reaction leading to selective and high-yielding 3-oxo-
3H-benzo[a]pyrano[2,3-c]phenazine-1-carboxylate and 3-(5-hydroxybenzo[a]phenazin-6-yl)acrylate derivatives from readily avaible
starting materials in aqueous medium. This protocol also offers several advantages such as convenient one-pot operation, high atom
economy, easy work-up, short reaction time, use of DABCO as a highly reactive, non-toxic and reusable catalyst and avoidance of
conventional volatile organic solvents that make it a green, economically cost-effective and attractive process for the synthesis of these
heterocycles. Furthermore, our work is expected to exhibit interesting pharmacology activities and may act as potential drug
candidates, since phenazine and pyran motifs have a vast range of biological activity.
4. Experimental
4.1. Chemistry
All melting points were determined on an Electrothermal 9100 apparatus and are uncorrected. IR spectra were recorded on a
shimadzu IR-470 spectrometer. Elemental analyses for C, H, and N were performed using a Heraeus CHN-O-Rapid analyzer at Iranian
Central Research of Petroleum Company. Mass spectra were recorded on an Agilent Technology (HP) spectrometer operating at an
1
ionization potential of 70 eV. The H NMR and 13C NMR spectra were recorded on a Bruker DRX-300 and 400 Avanve instrument
with CDCl3 and DMSO-d6 as solvent and using TMS as internal reference at 300, 400, 75, and 100 MHz, respectively. Thin-layer
chromatography (TLC) was performed on silica-gel Polygram SILG/UV 254 plates. All reagents and solvent were purchased from
Merck and Aldrich and used without further purification.
4.2. General procedure for the synthesis of novel 3-oxo-3H-benzo[a]pyrano[2,3-c]phenazine-1-carboxylate and 3-(5-hydroxybenzo-
[a]phenazin-6-yl)acrylate derivatives (6, 7)
Initially, a mixture of 2-hydroxynaphthalene-1,4-dione 1 (1 mmol), benzene-1,2-diamine 2 (1 mmol), DABCO (20 or 10 mol%) and
water (10 mL) was placed in a 50 mL round-bottomed flask mounted over a magnetic stirrer. The contents were stirred magnetically in
an oil-bath maintained at 50 °C until in less than 10 minutes benzo[a]phenazin-5-ol 3 was formed. Then, dialkyl
acetylenedicarboxylate 4 (1 mmol) or alkyl propiolate 5 (1 mmol) was added to the above reaction mixture which was heated further at
the same temperature for an appropriate time as shown in Tables 2 and 4. Upon completion of the reaction, monitored by TLC, the
reaction mixture was allowed to cool to room temperature. Then, 5 mL of water was added to the mixture and filtered for separation of
the crude product. The separated product was washed twice with water (2×5 mL). The solid crude product subsequently recrystallized
from hot ethanol to give the pure product 6 and 7. Some spectral and analytical data are presented below, others are deposited in
Supporting information.
Methyl 3-oxo-3H-benzo[a]pyrano[2,3-c]phenazine-1-carboxylate (6a): Brown powder; yield 0.334 g (94%), mp 243-245 °C; IR
1
(KBr, cm–1): νmax 1729 (C=O); H NMR (400 MHz, CDCl3): δ 4.18 (s, 3H, OCH3), 6.61 (s, 1H, CH), 7.86-7.94 (m, 4H, Ar-H), 8.11-
8.13 (m, 1H, Ar-H), 8.30-8.32 (m, 1H, Ar-H), 8.56-8.58 (m, 1H, Ar-H), 9.31-9.33 (m, 1H, Ar-H); 13C NMR (100 MHz, CDCl3): δ 52.9
(OCH3), 108.5 (CH), 113.9, 123.5, 125.0, 125.5, 128.7, 129.7, 130.3, 130.6, 130.8, 131.0, 132.0, 137.9, 139.7, 141.2, 141.5, 146.9 and
155.5 (17Colefinic and Carom), 159.2 and 166.9 (2C=O); MS (m/z, %): 356 (M+, 74), 297 (100), 241 (67), 125 (19), 97 (62), 57 (83);
Anal. Calcd. for C21H12N2O4: C, 70.78; H, 3.39; N, 7.86. Found: C, 70.96; H, 3.51; N, 8.01.
Methyl 12-methyl-3-oxo-3H-benzo[a]pyrano[2,3-c]phenazine-1-carboxylate (6c): Yellow powder; yield 0.342 g (92%), mp 234-
1
236 °C; IR (KBr, cm–1): νmax 1721 (C=O); H NMR (400 MHz, CDCl3): δ 2.51 (s, 3H, CH3), 4.19 (s, 3H, OCH3), 6.64 (s, 1H, CH),
7.90-7.96 (m, 3H, Ar-H), 7.99 (td, 1H, J1 = 6.0 Hz, J2 = 1.2 Hz, Ar-H), 8.36-8.39 (m, 1H, Ar-H), 8.65-8.67 (m, 1H, Ar-H), 9.42-9.44
(m, 1H, Ar-H); 13C NMR (100 MHz, CDCl3): δ 22.5 (CH3), 52.7 (OCH3), 108.3 (CH), 113.1, 123.9, 124.5, 125.6, 128.7, 129.7, 130.5,
131.6, 131.7, 132.9, 133.1, 137.3, 139.9, 140.3, 140.4, 143.4 and 155.2 (17Colefinic and Carom), 159.9 and 166.2 (2C=O); MS (m/z, %):
370 (M+, 100), 311 (92), 284 (90), 188 (14), 127 (36), 69 (64): Anal. Calcd. for C22H14N2O4: C, 71.35; H, 3.81; N, 7.56. Found: C,
71.57; H, 3.69; N, 7.70.
Methyl 11-nitro-3-oxo-3H-benzo[a]pyrano[2,3-c]phenazine-1-carboxylate (6e): Yellow powder; yield 0.353 g (88%), mp 260-262
1
°C; IR (KBr, cm–1): νmax 1747, 1726 (2C=O); H NMR (300 MHz, DMSO-d6): δ 4.11 (s, 3H, OCH3), 6.97 (s, 1H, CH), 7.88-8.04 (m,
2H, Ar-H), 8.28-8.44 (m, 2H, Ar-H), 8.57-8.68 (m, 1H, Ar-H), 8.83 (s, 1H, Ar-H), 9.12-9.18 (m, 1H, Ar-H); 13C NMR (75 MHz,
DMSO-d6): δ 52.8 (OCH3), 108.3 (CH), 112.9, 121.5, 123.6, 125.9, 128.3, 129.7, 129.8, 130.8, 131.6, 131.8, 132.2, 137.4, 139.8,
141.1, 141.6, 147.8 and 155.2 (17Colefinic and Carom), 159.2 and 166.4 (2C=O); MS (m/z, %): 401 (M+, 2), 311 (60), 284 (100), 255 (59),
127 (26), 69 (90); Anal. Calcd. for C21H11N3O6: C, 62.85; H, 2.76; N, 10.47. Found: C, 62.76; H, 2.99; N, 10.41.
Methyl 3-(5-hydroxybenzo[a]phenazin-6-yl)acrylate (7a): Yellow powder; yield 0.304 g (92%), mp 134-136 °C; IR (KBr, cm–1):
1
νmax 1714 (C=O); H NMR (300 MHz, CDCl3): δ 3.84 (s, 3H, OCH3), 5.52 (d, 1H, J = 6.6 Hz, CH), 6.00 (d, 1H, J = 12.0 Hz, CH),
7.37-7.50 (m, 1H, Ar-H), 7.87-7.90 (m, 3H, Ar-H), 8.14-8.36 (m, 3H, Ar-H), 9.41 (d, 1H, J = 6.0 Hz, Ar-H), 11.80 (s, 1H, OH); 13C
NMR (75 MHz, CDCl3): δ 51.6 (OCH3), 105.2, 108.4, 122.3, 125.4, 127.2, 128.7, 129.0, 129.5, 129.7, 129.9, 130.2, 131.6, 140.7,